Autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosages

BMJ Case Reports

Volumn , Issue , 2009, Pages

  Bunck, Mathijs C ^a   Debono, Miguel ^b   Giltay, Erik J ^c   Verheijen, Andreas T ^a   Diamant, Michaela ^a   Gooren, Louis J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955562871     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.02.2009.1589     Document Type: Article

References (16)

1. Asscheman H, Gooren LJ, Assies J, et al. Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals. Clin Endocrinol (Oxf) 1988; 28: 583-8. [Medline]
2. Levy A, Crown A, Reid R. Endocrine intervention for transsexuals. Clin Endocrinol 2003; 59: 409-18. [CrossRef] [Medline] (Pubitemid 37188168)
3. Gooren LJ, Assies J, Asscheman H, et al. Estrogen-induced prolactinoma in a man. J Clin Endocrinol Metab 1988; 66: 444-6. [CrossRef] [Medline] [Web of Science] (Pubitemid 18065194)
4. Futterweit W. Endocrine therapy of transsexualism and potential complications of long-term treatment. Arch Sex Behav 1998; 27: 209-26. [CrossRef] [Medline] [Web of Science] (Pubitemid 28169357)
5. Kovacs K, Stefaneanu L, Ezzat S, et al. Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic study. Arch Pathol Lab Med 1994; 118: 562-5. [Medline] [Web of Science] (Pubitemid 24176837)
6. Serri O, Noiseux D, Robert F, et al. Lactotroph hyperplasia in an estrogen treated male-to-female transsexual patient. J Clin Endocrinol Metab 1996; 81: 3177-9. [CrossRef] [Medline] [Web of Science] (Pubitemid 26296184)
7. Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocrine Rev 2001; 22: 724-63. [CrossRef] [Medline] [Web of Science] (Pubitemid 34214293)
8. Nishihara E, Nagayama Y, Inoue S, et al. Ontogenetic changes in the expression of estrogen receptor alpha and beta in rat pituitary gland detected by immunohistochemistry. Endocrinology 2000; 141: 615-20. [CrossRef] [Medline] [Web of Science] (Pubitemid 32250485)
9. Velkeniers B. From prolactin cell to prolactinoma. Verh K Acad Geneeskd Belg 2001; 63: 561-73. [Medline]
10. Spady TJ, Harvell DM, Snyder MC, et al. Estrogen-induced tumorigenesis in the Copenhagen rat: disparate susceptibilities to development of prolactin-producing pituitary tumors and mammary carcinomas. Cancer Lett 1998; 124: 95-103. [CrossRef] [Medline] [Web of Science] (Pubitemid 28073814)
11. Spady TJ, McComb RD, Shull JD. Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland. Endocrine 1999; 11: 217-33. [CrossRef] [Medline] [Web of Science] (Pubitemid 30163331)
12. Teip CS. The regression of oestradiol-induced pituitary tumours in the rat. J Pathol 1983; 141: 29-40. [CrossRef] [Medline] [Web of Science]
13. Ishida M, Takahashi W, Itoh S, et al. Estrogen actions on lactotroph proliferation are independent of a paracrine interaction with other pituitary cell types: a study using lactotroph-enriched cells. Endocrinology 2007; 148: 3131-9. [CrossRef] [Medline] [Web of Science] (Pubitemid 46996984)
14. Asa SL, Kelly MA, Grandy DK, et al. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 1999; 140: 5348-55. [CrossRef] [Medline] [Web of Science]
15. Kochman K, Joseph JA, Blackman MR, et al. Impaired down-regulation of pituitary dopamine receptors by estradiol in aged rats. Proc Soc Exp Biol Med 1989; 192: 23-6. [Abstract/FREE Full text] (Pubitemid 19260261)
16. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009. In press. Search Google Scholar